USP7 and small cell lung carcinoma: Using a PDX model, Grunblatt et al. identified the deubiquitinase USP7 as a MYCN-associated synthetic vulnerability in small cell lung cancer (SCLC) by a genome-scale CRISPR-Cas9 screening.